Assignee
IMMUNOMEDICS INC
US·348 granted patents·132 pending applications·17,136 citations·filing 1983–2025
Top patents by PatentIndex Score
480 records- 0199US11541047B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2020·Granted Jan 3, 2023·5 cites·16 claims
- 0299US9492566B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2015·Granted Nov 15, 2016·61 cites·22 claims
- 0399US7999083B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2009·Granted Aug 16, 2011·184 cites·13 claims
- 0499US7931903B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2010·Granted Apr 26, 2011·97 cites·38 claims
- 0599US7772373B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Aug 10, 2010·114 cites·35 claims
- 0699US7662378B2Antibody therapyIMMUNOMEDICS INC·Filed 2007·Granted Feb 16, 2010·73 cites·18 claims
- 0799US7641901B2Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2005·Granted Jan 5, 2010·76 cites·47 claims
- 0899US7591994B2Camptothecin-binding moiety conjugatesIMMUNOMEDICS INC·Filed 2008·Granted Sep 22, 2009·129 cites·14 claims
- 0999US7563433B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Jul 21, 2009·64 cites·16 claims
- 1099US7312318B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 25, 2007·243 cites·23 claims
- 1199US7109304B2Humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2004·Granted Sep 19, 2006·240 cites·4 claims
- 1299US7074403B1Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2000·Granted Jul 11, 2006·226 cites·20 claims
- 1399US6653104B2Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cellsIMMUNOMEDICS INC·Filed 2001·Granted Nov 25, 2003·346 cites·140 claims
- 1499US6472511B1Stimulation of an immune response with antibodies labeled with the α-galactosyl epitopeIMMUNOMEDICS INC·Filed 2000·Granted Oct 29, 2002·160 cites·5 claims
- 1599US6331175B1Method and kit for imaging and treating organs and tissuesIMMUNOMEDICS INC·Filed 1998·Granted Dec 18, 2001·239 cites·15 claims
- 1699US6306393B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1999·Granted Oct 23, 2001·674 cites·33 claims
- 1799US6183744B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1998·Granted Feb 6, 2001·386 cites·23 claims
- 1899US5697902AMethod for imaging and treating organs and tissuesIMMUNOMEDICS INC·Filed 1995·Granted Dec 16, 1997·289 cites·14 claims
- 1999US4925648ADetection and treatment of infectious and inflammatory lesionsIMMUNOMEDICS INC·Filed 1988·Granted May 15, 1990·518 cites·16 claims
- 2098US11116846B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Sep 14, 2021·8 cites·16 claims
- 2198US11020489B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2020·Granted Jun 1, 2021·4 cites·16 claims
- 2298US10849986B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Dec 1, 2020·5 cites·15 claims
- 2398US10682347B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2018·Granted Jun 16, 2020·11 cites·18 claims
- 2498US10137196B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2016·Granted Nov 27, 2018·18 cites·20 claims
- 2598US9187561B2Humanized anti-HLA-DR antibodiesIMMUNOMEDICS INC·Filed 2014·Granted Nov 17, 2015·35 cites·21 claims
- 2698US9138485B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2014·Granted Sep 22, 2015·32 cites·15 claims
- 2798US9028833B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2013·Granted May 12, 2015·48 cites·22 claims
- 2898US8992917B2Humanized L243 antibodiesIMMUNOMEDICS INC·Filed 2013·Granted Mar 31, 2015·37 cites·23 claims
- 2998US8759496B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2012·Granted Jun 24, 2014·38 cites·16 claims
- 3098US7993626B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Aug 9, 2011·37 cites·16 claims
- 3198US7910103B2Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Mar 22, 2011·77 cites·22 claims
- 3298US7902338B2Anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2008·Granted Mar 8, 2011·47 cites·11 claims
- 3398US7585491B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2003·Granted Sep 8, 2009·148 cites·40 claims
- 3498US7541440B2Chimeric, human and humanized anti-granulocyte antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Jun 2, 2009·129 cites·24 claims
- 3598US7462352B2Methods of treatng B-cell diseases using humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2006·Granted Dec 9, 2008·74 cites·21 claims
- 3698US7300655B2Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereofIMMUNOMEDICS INC·Filed 2003·Granted Nov 27, 2007·109 cites·19 claims
- 3798US7282567B2Monoclonal antibody hPAM4IMMUNOMEDICS INC·Filed 2003·Granted Oct 16, 2007·143 cites·43 claims
- 3898US7238785B2RS7 antibodiesIMMUNOMEDICS INC·Filed 2003·Granted Jul 3, 2007·237 cites·8 claims
- 3998US7151164B2Anti-CD20 antibodies and fusion proteins thereof and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 19, 2006·290 cites·16 claims
- 4098US6962702B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Nov 8, 2005·126 cites·30 claims
- 4198US6187287B1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1998·Granted Feb 13, 2001·402 cites·34 claims
- 4298US6096289AIntraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapyIMMUNOMEDICS INC·Filed 1998·Granted Aug 1, 2000·274 cites·23 claims
- 4398US5789554AImmunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1996·Granted Aug 4, 1998·596 cites·32 claims
- 4498US5716595AIntraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragmentsIMMUNOMEDICS INC·Filed 1994·Granted Feb 10, 1998·307 cites·52 claims
- 4598US5443953APreparation and use of immunoconjugatesIMMUNOMEDICS INC·Filed 1993·Granted Aug 22, 1995·338 cites·17 claims
- 4697US10653793B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2018·Granted May 19, 2020·8 cites·11 claims
- 4797US10195175B2Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitorsIMMUNOMEDICS INC·Filed 2017·Granted Feb 5, 2019·18 cites·12 claims
- 4897US10130626B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2016·Granted Nov 20, 2018·18 cites·16 claims
- 4997US10130718B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2016·Granted Nov 20, 2018·12 cites·10 claims
- 5097US10064957B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2017·Granted Sep 4, 2018·14 cites·24 claims
Showing the top 50 of 480 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →